- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · May 20, 2026 | 5.29M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 1.45M sh |
| Shares Diluted | Q3 2026 · Mar 31, 2026 | 1.2M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 1.05M sh |
| Shares Diluted restated | Q3 2026 · Mar 31, 2025 | 1.05M sh |
| Operating Cash Flow | Q3 2026 · Mar 31, 2026 | $430.4K |
| Operating Cash Flow | Q3 2026 · Mar 31, 2025 | −$500.21K |
| Cash And Equivalents | Q3 2026 · Mar 31, 2026 | $713.69K |
| Cash And Equivalents | Q3 2026 · Jun 30, 2025 | $1.68M |
| Current Liabilities | Q3 2026 · Mar 31, 2026 | $6.6M |
| Current Liabilities | Q3 2026 · Jun 30, 2025 | $14.45M |
| Total Liabilities | Q3 2026 · Mar 31, 2026 | $14.16M |
| Total Liabilities | Q3 2026 · Jun 30, 2025 | $17.37M |
| Current Assets | Q3 2026 · Mar 31, 2026 | $14.5M |
| Current Assets | Q3 2026 · Jun 30, 2025 | $19.37M |
| Total Assets | Q3 2026 · Mar 31, 2026 | $31.31M |
| Total Assets | Q3 2026 · Jun 30, 2025 | $35.64M |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$2.38 |
| Eps Diluted | Q3 2026 · Mar 31, 2026 | −$4.32 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$0.33 |
| Eps Diluted restated | Q3 2026 · Mar 31, 2025 | −$2.06 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$2.38 |
| Eps Basic | Q3 2026 · Mar 31, 2026 | −$4.32 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$0.33 |
| Eps Basic restated | Q3 2026 · Mar 31, 2025 | −$2.06 |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$1.14M |
| Operating Income | Q3 2026 · Mar 31, 2026 | −$5.14M |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$334.5K |
| Operating Income restated | Q3 2026 · Mar 31, 2025 | −$2.82M |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $755.55K |
| Gross Profit | Q3 2026 · Mar 31, 2026 | $6.84M |
| Gross Profit restated | Q3 2026 · Mar 31, 2025 | $6.86M |
| Gross Profit restated | Q3 2026 · Mar 31, 2025 | $22.9M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $2.74M |
| Cost Of Revenue | Q3 2026 · Mar 31, 2026 | $11.69M |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $9.19M |
| Cost Of Revenue restated | Q3 2026 · Mar 31, 2025 | $29.75M |